|
|
Article: ARTS: Landmark Randomized Clinical Trial Compares Efficacy of Coronary Stents vs. Bypass Surgery For Treating Multivessel Coronary Artery Disease.
- Article from:
- PR Newswire
- Article date:
- August 30, 1999
CopyrightCOPYRIGHT 1999 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Study Suggests Stents Can Save $4,500 Per Patient
In-Hospital Costs Compared to Bypass Surgery
BARCELONA, Spain, Aug. 30 /PRNewswire/ -- One-year follow-up results of a large-scale randomized clinical trial involving 1,200 patients and comparing Cordis Corporation's minimally invasive Palmaz-Schatz(R) CROWN and CrossFlex(TM) Coronary Stents to more invasive bypass surgery (CABG) indicates stents may be a feasible and effective way of treating multivessel coronary artery disease.
The study results also found the average waiting time (from decision to treat to actual treatment) for patients undergoing CABG (Coronary Artery Bypass Graft) procedures ...